Tyra Biosciences, Inc. Common Stock

TYRANASDAQ • USD
ThemeHealthcare - Oncology›Targeted Therapy & Precision Oncology
20.39 USD
↗ 0.15 (0.74%)AT CLOSE (03:59 PM EDT)
20.38
↘ 0.01 (0.05%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
20.38
↘ 0.01 (0.05%)
🔴Market: CLOSED

Tyra Biosciences, Inc. Common Stock (TYRA) is currently trading at $20.38. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place TYRA at a fair price relative to peers.

Technical & fundamental data as of Oct 7, 2026.

Open?$19.97
High?$20.79
Low?$19.80
Prev. Close?$20.24
Volume?477.7K
Avg. Volume?1.2M
VWAP?$20.28
Rel. Volume?0.41x
Bid / Ask
Bid?$16.57 × 100
Ask?$26.22 × 100
Spread?$9.65
Midpoint?$21.40
Valuation & Ratios
Market Cap?1.4B
Shares Out?59.7M
Float?33.4M
Float %?56.2%
P/E Ratio?N/A
P/B Ratio?3.93
EPS?-$2.16
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
Themes
Healthcare - Oncology›Targeted Therapy & Precision OncologyBiotech - Drug Development›Clinical-Stage Platforms
Employees
87
Market Cap
1.4B
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.tyra.bio
Listed
2021-09-15
Address
2656 STATE STREET
CARLSBAD, CA 92008
Phone: (619) 728-4760
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
23
Short Sent.?
23
Piotroski F-Score?0/9Weak
Altman Z-Score?26.14Safe
Confidence?48%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?29.54%Squeeze Risk
Short Interest?9.9M
Days to Cover?5.7
Free Float33.4M
Avg Daily Volume1.7M
Settlement Date2026-09-15
Financial Health
Current Ratio?14.91Strong
Quick Ratio?14.91Strong
Cash Ratio?3.00Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
45
3.93FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-8.2CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-41.9%WEAK▾
ROA?
S&P
3
-38.7%WEAK▾
Cash Flow & Enterprise
FCF?$-109901000
Enterprise Value?$1.3B
Fundamentals ratios updated end of day
MarketsMoversWatchlist